Effects of magnesium supplementation in hypertensive patients: Assessment by office, home, and ambulatory blood pressures

Hypertension

Volumn 32, Issue 2, 1998, Pages 260-265

  Kawano, Yuhei ^a   Matsuoka, Hiroaki ^a   Takishita, Shuichi ^a   Omae, Teruo ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Blood pressure; Blood pressure, ambulatory; Hypertension, essential; Magnesium; Nonpharmacological treatment

Indexed keywords

MAGNESIUM;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIET SUPPLEMENTATION; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; LIFESTYLE; MAGNESIUM BLOOD LEVEL; MAGNESIUM METABOLISM; MAGNESIUM URINE LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031843971     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.2.260     Document Type: Article

References (35)

1. Altura BM, Altura BT. Role of magnesium in the pathogenesis of hypertension updated: relationship to its actions on cardiac, vascular smooth muscle, and endothelial cells. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press; 1995:1213-1242.
2. Kesteloot H, Joossens JV. Relationship of dietary sodium, potassium, calcium, and magnesium with blood pressure: Belgian Interuniversity Research on Nutrition and Health. Hypertension. 1988;12:594-599.
3. Witteman JCM, Willett WC, Stampfer MJ, Colditz GA, Sacks FM, Speizer FE, Rosner B, Hennekens CH. A prospective study of nutritional factors and hypertension among US women. Circulation. 1989;80: 1320-1327.
4. Harlan WR, Harlac LC. Blood pressure and calcium and magnesium intake. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press; 1995;1143-1154.
5. Uza G, Pavel O, Uza D, Valaicu R. Hypomagnesemia in patients with essential arterial hypertension. Magnes Bull. 1987;9:177-180.
6. + in platelets and erythrocytes of essential hypertension patients: relation to blood pressure. Clin Exp Hypertens. 1992;A14:1189-1209.
7. Altura BM, Altura BT. Role of magnesium in pathophysiologicai processes and the clinical utility of magnesium ion selective electrodes. Scand J Clin Lab Invest. 1996;224(suppl):211-234.
8. Altura BM, Altura BT, Gebrewold A, Ising H, Gunther T. Magnesium-deficiency and hypertension: correlation between magnesium-deficient diets and microcirculatory changes in situ. Science. 1984;223:1315-1317.
9. Adachi M, Nara Y, Mano M, Yamori Y. Effect of dietary magnesium supplementation on intralymphocytic free calcium and magnesium in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens. 1994; 16:317-326.
10. Dyckner T, Wester PO. Effect of magnesium on blood pressure. BMJ. 1983;286:1847-1849.
11. Motoyama T, Sano H, Fukuzaki H. Oral magnesium supplementation in patients with essential hypertension. Hypertension. 1989;13:227-232.
12. Widman L, Wester PO, Stegmyr BK, Wirrel M. The dose-dependent reduction in blood pressure through administration of magnesium: a double blind placebo controlled cross-over study. Am J Hypertens. 1993; 6:41-45.
13. Trials of Hypertension Prevention Collaborative Research Group. The effects of nonpharmacological interventions on blood pressure of persons with high normal levels: results of the Trials of Hypertension Prevention, phase I. JAMA. 1992;267:1213-1220.
14. Ferrara LA, Iannuzzi R, Costaldo A, Ianuzzi A, Dello Russo A, Mancini M. Long-term magnesium supplementation in essential hypertension. Cardiology. 1992;81:25-33.
15. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
16. Alderman MH. Non-pharmacological treatment of hypertension. Lancet. 1994;344:307-311.
17. Appel LJ, Stason WB. Ambulatory blood pressure monitoring and blood pressure self-measurement in the diagnosis and management of hypertension. Ann Intern Med. 1993;118:867-882.
18. Kawano Y, Abe H, Kojima S, Ashida T, Yoshida K, Imanishi M, Yoshimi H, Kimura G, Kuramochi M, Omae T. Acute depressor effect of alcohol in patients with essential hypertension. Hypertension. 1992;20: 219-226.
19. Kawano Y, Abe H, Kojima S, Yoshimi H, Sanai T, Kimura G, Matsuoka H, Takishita S, Omae T. Different effects of alcohol and salt on 24-hour blood pressure and heart rate in hypertensive patients. Hypertens Res. 1996;19:255-261.
20. +-ATPase activity in essential hypertension. Jpn Heart J. 1992;33:785-800.
21. Mansoor GA, White WB. Contribution of ambulatory blood pressure monitoring to the design and analysis of antihypertensive therapy trials. J Cardiovasc Risk. 1994;1:136-142.
22. Imai Y, Sasaki S, Minami N, Munakata M, Hashimito T, Sakuma H, Sakuma M, Watanabe N, Imai K, Sekino H, Abe K. The accuracy and performance of the A&D TM2421, a new ambulatory blood pressure monitoring device based on the cuff-oscillometric and the Korotkoff sound technique. Am J Hypertens. 1992;5:719-726.
23. Altura BM, Altura BT. Cardiovascular risk factors and magnesium: relationships to atherosclerosis, ischemic heart disease and hypertension. Magnes Trace Elem. 1991-92;10:182-192.
24. Continuing Survey of Food Intake by Individuals 1989 and 1990. US Dept of Agriculture Public Use Data Tape; 1989.
25. Itokawa Y. Calcium and magnesium intake of Japanese [in Japanese]. Saisin Igaku. 1983;38:641-645.
26. US National Research Council. Recommended Dietary Allowances. 10th ed. Washington, DC: National Academy Press; 1989.
27. Ministry of Health and Welfare. Nutritional Allowances in Japanese [in Japanese]. 5th ed. Tokyo. Japan: Ministry of Health and Welfare; 1994.
28. Witteman JCM, Grobbee DE, Derkx FHM, Bouillon R, de Bruijn AM, Hofman R. Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr. 1994;60:129-135.
29. Zenel PC, Zenel MB, Urberg M, Douglas FL, Geiser R, Sowers JR. Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension. Am J Clin Nutr. 1990;51:665-669.
30. Cappuccio FP, Markandu MD, Beynon GW, Shore AC, Sampson B, MacGregor GA. Lack of effect of oral magnesium on high blood pressure: a double blind study. BMJ. 1985;291:235-238.
31. Kesteloot H, Huang DX, Li Y, Gebores J, Joosens JV. The relationship between cations and blood pressure in the People's Republic of China. Hypertension. 1987;9:654-659.
32. Kesteloot H, Ndam N, Sasaki S, Kowo M, Seghers V. A survey of blood pressure distribution in Pigmy and Bantu populations in Cameroon. Hypertension. 1996;27:108-113.
33. Altura BM, Altura BT. Role of magnesium in the pathogenesis of hypertension updated: relationship to its actions on cardiac and vascular smooth muscle. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. New York, NY: Raven Press; 1990: 1003-1025.
34. Lind L, Lithell H, Pollare T. Ljunghall S. Blood pressure response during long-term treatment with magnesium is dependent on magnesium status: a double-blind placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure. Am J Hypertens. 1991;4: 674-679.
35. Kojima S, Murakami K, Kimura G, Sanai T, Yoshida K, Imanishi M, Abe H, Kawamura M, Kawano Y, Ashida T, Yoshimi H, Kuramochi M, Omae T, Ito K. A gender difference in the association between salt sensitivity and family history of hypertension. Am J Hypertens. 1992;5:1-7.